Isabelle Vandenberghe

809 total citations
17 papers, 450 citations indexed

About

Isabelle Vandenberghe is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Isabelle Vandenberghe has authored 17 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Isabelle Vandenberghe's work include Cancer Treatment and Pharmacology (3 papers), Natural product bioactivities and synthesis (3 papers) and Ubiquitin and proteasome pathways (3 papers). Isabelle Vandenberghe is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Natural product bioactivities and synthesis (3 papers) and Ubiquitin and proteasome pathways (3 papers). Isabelle Vandenberghe collaborates with scholars based in France, Germany and Netherlands. Isabelle Vandenberghe's co-authors include Anna Kruczynski, Laurent Créancier, Bruno Gomes, Christian Bailly, Nicolas Guilbaud, Jean‐Marc Barret, Stéphane Vispé, Laurence Lamant, Jean‐Philippe Annereau and Jean Edouard Gairin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Isabelle Vandenberghe

17 papers receiving 444 citations

Peers

Isabelle Vandenberghe

ONCOL

IMMUN

PRM

Jessica Plati United States

Kathryn J. Chavez United States

Jean‐Philippe Annereau France

Ailian Xiong United States

Lingyuan Xu China

Robert E. Gerl Australia

Lu Wen China

Moon-Taek Park South Korea

Patrick Corsino United States

Young Ju Yoon South Korea

Jessica Plati United States

Isabelle Vandenberghe

354 ×1.3

112 ×0.7

ONCOL

51 ×0.8

42 ×0.7

IMMUN

41 ×0.8

PRM

Citations per year, relative to Isabelle Vandenberghe Isabelle Vandenberghe (= 1×) peers Jessica Plati

Countries citing papers authored by Isabelle Vandenberghe

Since Specialization

Citations

This map shows the geographic impact of Isabelle Vandenberghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Vandenberghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Vandenberghe more than expected).

Fields of papers citing papers by Isabelle Vandenberghe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Vandenberghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Vandenberghe. The network helps show where Isabelle Vandenberghe may publish in the future.

Co-authorship network of co-authors of Isabelle Vandenberghe

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Vandenberghe. A scholar is included among the top collaborators of Isabelle Vandenberghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Vandenberghe. Isabelle Vandenberghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Melero, Ignacio, Carlos Gomez‐Roca, Pierre Ferré, et al.. (2020). 315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody. SHILAP Revista de lepidopterología. A193.2–A194. 5 indexed citations

Pillon, Arnaud, Bruno Gomes, Isabelle Vandenberghe, et al.. (2017). Actinic keratosis modelling in mice: A translational study. PLoS ONE. 12(6). e0179991–e0179991. 10 indexed citations

Pillon, Arnaud, et al.. (2016). Discovery Bioanalysis and In Vivo Pharmacology as an Integrated Process: A Case Study in Oncology Drug Discovery. Bioanalysis. 8(14). 1481–1498. 2 indexed citations

Créancier, Laurent, Isabelle Vandenberghe, Bruno Gomes, et al.. (2015). Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma. Cancer Letters. 365(1). 107–111. 71 indexed citations

Thibault, Benoît, Emily Clement, Samuel Meignan, et al.. (2015). F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer. Cancer Letters. 370(1). 10–18. 20 indexed citations

Créancier, Laurent, et al.. (2015). Abstract 4265: Identification of new NTRK1 gene fusion as oncogene target in colon cancer. Cancer Research. 75(15_Supplement). 4265–4265. 1 indexed citations

Kruczynski, Anna, Arnaud Pillon, Laurent Créancier, et al.. (2013). F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity. Leukemia. 27(11). 2139–2148. 30 indexed citations

Riond, Joëlle, Isabelle Vandenberghe, Bruno Gomes, et al.. (2012). Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells. PLoS ONE. 7(5). e36762–e36762. 89 indexed citations

Long, Christophe, Laurence Marcourt, Fadila Derguini, et al.. (2011). Semisynthetic neoboutomellerone derivatives as ubiquitin-proteasome pathway inhibitors. Bioorganic & Medicinal Chemistry. 20(2). 819–831. 4 indexed citations

10.

Pouny, Isabelle, Stéphane Vispé, Laurence Marcourt, et al.. (2011). Four New Carvotanacetone Derivatives fromSphaeranthus ukambensis, Inhibitors of the Ubiquitin-Proteasome Pathway. Planta Medica. 77(14). 1605–1609. 10 indexed citations

11.

Long, Christophe, Laurence Marcourt, Laure Vendier, et al.. (2011). Proteasome Inhibitors from Neoboutonia melleri. Journal of Natural Products. 75(1). 34–47. 14 indexed citations

12.

Créancier, Laurent, Arnaud Pillon, Julien Verdier, et al.. (2010). 273 Use of bioluminescence imaging and quantitative RT-PCR to monitor tumor progression and treatment response in orthotopic AML mouse models: Application to the targeted cytotoxic agent F14512. European Journal of Cancer Supplements. 8(7). 89–89. 1 indexed citations

13.

Kruczynski, Anna, Isabelle Vandenberghe, Arnaud Pillon, et al.. (2009). Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system. Investigational New Drugs. 29(1). 9–21. 50 indexed citations

14.

Vandenberghe, Isabelle, Laurent Créancier, Stéphane Vispé, et al.. (2008). Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis. Biochemical Pharmacology. 76(4). 453–462. 55 indexed citations

15.

Vispé, Stéphane, Isabelle Vandenberghe, Maxime Robin, et al.. (2007). Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome. Biochemical Pharmacology. 73(12). 1863–1872. 37 indexed citations

16.

Ausseil, Fréderic, Arnaud Samson, Isabelle Vandenberghe, et al.. (2006). High-Throughput Bioluminescence Screening of Ubiquitin-Proteasome Pathway Inhibitors from Chemical and Natural Sources. SLAS DISCOVERY. 12(1). 106–116. 21 indexed citations

17.

Devreese, Bart, et al.. (2001). Identification of beta-endorphins in the pituitary gland and blood plasma of the common carp (Cyprinus carpio). Journal of Endocrinology. 169(2). 271–280. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact